LENORA TAYLOR: Open Payments
NPI 1619619178 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,263 in 116 payments from 20 companies in 2025. Trend: 2023 $1,814 · 2024 $1,907 · 2025 $2,263
Food & beverage: $2,203Education: $60
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 20 | $322 |
| Astellas Pharma US Inc | 15 | $293 |
| GlaxoSmithKline, LLC. | 18 | $275 |
| Novo Nordisk Inc | 11 | $265 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $201 |
| ABBVIE INC. | 10 | $165 |
| AstraZeneca Pharmaceuticals LP | 2 | $155 |
| Lilly USA, LLC | 5 | $82 |
| SANOFI-AVENTIS U.S. LLC | 3 | $74 |
| Corcept Therapeutics | 3 | $72 |
Products named: REXULTI, Veozah, JARDIANCE, TRELEGY ELLIPTA, Ozempic, FARXIGA, VRAYLAR, Wegovy.
Industry payments across TX — which companies pay providers there.
